Increase in prevalence of autoimmune diseases, rise in technological advancements, and rise in awareness about early diagnosis are the major factors which drive the global market growth. Increasing ...

According to industry analysis, increasing cases of rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis, celiac disease, and other chronic autoimmune conditions are driving testing ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. “We've always said that acquiring local laboratories or ...

Exagen Inc. has reached a major milestone by completing its 1,000,000th AVISE CTD test, a diagnostic tool for autoimmune and connective tissue diseases. This achievement highlights the company’s ...

BURLINGTON, N.C.--(BUSINESS WIRE)-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and ...

Add Yahoo as a preferred source to see more of our stories on Google. Autoimmune diseases are on the rise. It’s not just a hunch—autoimmune diseases are rising sharply, and the numbers are too ...

Exagen delivered record first-quarter revenue and improved adjusted EBITDA metrics as the autoimmune diagnostics company ...

An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only small samples of blood, a feature that makes it ideal to screen pediatric ...

Researchers are testing CAR T-cell therapy as a treatment for lupus, Graves’ disease and other conditions in which the body’s ...

The MarketWatch News Department was not involved in the creation of this content. CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune ...